The Indian government has announced its intention to amend the Medical Devices Rules, 2017, in order to accelerate the licensing process for medical devices, particularly those categorized as moderate to high risk. This move comes as part of broader efforts to streamline regulatory procedures, enhance the ease of doing business, and ensure that essential medical equipment becomes available to patients more quickly. According to reports, the Union Ministry of Health and Family Welfare has released a draft notification proposing significant reductions in the time required to obtain manufacturing licenses for certain classes of medical devices. These amendments aim to maintain rigorous standards of quality, safety, and performance while making the regulatory environment more efficient and transparent.
The proposed changes focus on reducing the statutory timelines for granting manufacturing licenses across different risk categories. Currently, under the Medical Devices Rules, 2017, medical devices are divided into four classifications based on risk: Class A, Class B, Class C, and Class D, with Class D representing the highest level of risk. The new proposals suggest that the time required to issue licenses for Class B devices—which include items such as blood pressure monitors, hypodermic needles, and pulse oximeters—will be shortened from 140 days to 115 days. Similarly, for Class C and Class D devices, which encompass high-risk products like cardiac stents, hip and knee implants, and other orthopedic implants, the timeline is being reduced from 105 days to 90 days. Class A devices, which consist of low-risk items such as medical thermometers and stethoscopes, remain unaffected by these changes.
In addition to shortening the overall timelines, the draft notification introduces clearly defined stages within the licensing process, including application scrutiny, audits conducted by notified bodies, compliance verification, and the actual issuance of licenses. These steps are designed to increase transparency and predictability in the regulatory framework. The health ministry emphasizes that this reform is intended to benefit both the medical device industry and patients by ensuring faster access to quality-assured medical equipment without compromising on safety or performance standards.
The proposed amendments were developed following extensive consultations with the Drugs and Technical Advisory Board (DTAB), which provided recommendations that informed the drafting of the notification. The draft has now been made publicly accessible for stakeholder feedback, allowing industry representatives, healthcare professionals, and other interested parties to comment on the proposed changes. Once the feedback is reviewed, the final version of the notification will be published in the Gazette of India, marking the formal implementation of the revised regulations.
Industry experts have welcomed the potential benefits of these reforms, noting that they could significantly reduce delays in bringing new medical technologies to market. However, some concerns have been raised about the adequacy of the measures in place to ensure continued compliance with safety and quality benchmarks. There is also anticipation that the streamlined process might lead to increased competition and innovation within the sector, potentially lowering costs and improving patient care outcomes.
Looking ahead, the government is expected to finalize the amendments and implement them in accordance with the feedback received during the public consultation phase. This step marks a crucial moment in the evolution of India's medical device regulation, reflecting a growing emphasis on balancing regulatory rigor with the need for agility and responsiveness in a rapidly advancing healthcare landscape. As the nation continues to navigate the complexities of modernizing its regulatory frameworks, the success of these reforms will likely serve as a benchmark for future policy decisions.
4 reports
Times of IndiaIndependentCenterFactual 98Objective 978 days agoThe Indian government is considering reforms to speed up the regulatory approval process for medical devices, aiming to reduce the time required for manufacturing licenses by up to 25 days. The proposed changes, outlined in draft amendments to the Medical Devices Rules, 2017, would shorten approval timelines for both Class B and Class C/D devices while maintaining existing safety and quality standards. Class B devices, such as blood pressure monitors and hypodermic needles, would see their approval period reduced from 140 days to 115 days. Class C and D devices, including cardiac stents and orthopedic implants, would face a reduction from 105 days to 90 days. The draft notification is open for public feedback before final implementation.
Bias read (Center): The article presents factual information about proposed regulatory changes without overtly favoring any political ideology. It focuses on administrative efficiency and regulatory reform, which are non-partisan issues. The framing remains neutral, providing balanced context about the proposed changes
Why these scores (Factual 98 · Objective 97): Very precise with specific timeline reductions for Class B, C, and D devices. Matches the consensus across sources and provides concrete examples of affected devices.
The HinduIndependentCenterFactual 97Objective 988 days agoThe Indian Union Ministry of Health and Family Welfare has proposed amendments to the Medical Devices Rules, 2017, aiming to shorten the timelines for granting manufacturing licenses for medical devices across different risk categories. Under the current rules, medical devices are classified into four risk-based categories—Class A, B, C, and D—with Class D being the highest risk. The proposed changes would reduce the license approval time for Class B devices from 140 days to 115 days and for Classes C and D from 105 days to 90 days. These amendments aim to improve regulatory efficiency, enhance ease of doing business, and ensure quicker availability of quality medical devices. The draft notification includes clearly defined timelines for each stage of the licensing process and is open for public feedback.
Bias read (Center): The article presents the proposed amendments as a regulatory update with a focus on streamlining processes and improving efficiency. It does not take a clear ideological stance, nor does it emphasize any particular political agenda. The framing remains neutral, focusing on the technical aspects of a
Why these scores (Factual 97 · Objective 98): Clear and concise summary of the proposed amendments. Provides correct classification of devices and mentions the date of the ministry's announcement, matching the consensus.
Hindustan TimesIndependentCenterFactual 96Objective 998 days agoThe Indian Union Ministry of Health and Family Welfare has proposed amendments to the Medical Devices Rules, 2017, aiming to shorten the licensing approval timelines for moderate to high-risk medical devices. Under the current rules, medical devices are categorized into four risk levels: Class A (low risk), Class B (moderate risk), Class C (high risk), and Class D (highest risk). The proposed changes would reduce the licensing time for Class B devices from 140 days to 115 days, and for Classes C and D from 105 days to 90 days. The reforms aim to streamline the regulatory process, improve efficiency, and ensure quicker availability of quality medical devices while maintaining safety and performance standards. The draft notification, issued on June 23, was based on recommendations from the Drugs and Technical Advisory Board (DTAB) following consultations. No changes are planned for Class A devices.
Bias read (Center): The article presents the proposal as a technical regulatory update based on expert recommendations and official documentation. It does not take a clear ideological stance, avoids loaded language, and reports the content of the draft notification without apparent bias toward any political faction. It
Why these scores (Factual 96 · Objective 99): Accurate with minor repetition of information. Mentions the June 23 draft notification and DTAB consultation, aligning with the cross-source consensus.
Hindustan TimesIndependentCenterFactual 95Objective 988 days ago Govt to amend rules for speedy approvals for medical devicesThe Indian government plans to amend the Medical Devices Rules, 2017, to expedite the licensing process for medical devices. The proposed changes aim to simplify and speed up approvals for moderate- to high-risk medical devices while maintaining quality, safety, and performance standards. Under the current rules, medical devices are categorized into four risk levels, with Class D being the highest risk. The amendments propose reducing approval times for Class B devices from 140 to 115 days and for Class C and D devices from 105 to 90 days. Class A devices, considered low-risk, would remain unaffected. The changes also introduce clear timelines for each stage of the licensing process, including application scrutiny, audits, and compliance verification.
Bias read (Center): The article presents a factual overview of proposed regulatory changes without overtly favoring any political side. It focuses on procedural updates to medical device approvals, emphasizing efficiency and compliance rather than ideological positions. There is no evident framing that leans toward one
Why these scores (Factual 95 · Objective 98): Highly accurate with specific details about the proposed amendments, citing the health ministry statement and DTAB consultation. Slightly less detailed than some others but still aligns closely with the cross-source consensus.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.
Become a Supporter
India
